Vaxcyte, Inc. logo PCVX - Vaxcyte, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 11
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $89.00 DETAILS
HIGH: $89.00
LOW: $89.00
MEDIAN: $89.00
CONSENSUS: $89.00
UPSIDE: 88.16%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Revenue
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 5.9 (5.0) 0 5.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit (5.9) 5.0 0 (5.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 312.8 242.1 209.9 194.2 148.1 133.6 116.9 131.5 94.6 104.2 97.4 72.7 58.1 51.6 47.7 38.5 31.7 23.1 20.4 17.7 17.3 14.7 16.4 18.2 24.3 13.4 9.6 10.0 12.6
SG&A Expenses 33.1 32.2 32.4 32.0 32.7 28.6 23.0 21.5 19.9 17.5 15.6 14.5 13.1 12.0 10.9 9.4 7.5 6.8 6.5 6.1 5.9 4.8 4.9 3.0 3.3 2.5 2.5 2.3 1.3
Other Expenses (5.9) 5.0 0 (5.0) 0 0 0 0 0 75 0 0 0 23.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 340.0 279.3 242.4 221.2 180.8 162.2 139.9 153.0 114.5 196.7 113.0 87.1 71.2 86.6 58.6 47.9 39.2 29.8 27.0 23.7 23.1 19.5 21.3 21.2 27.6 15.8 12.1 12.2 13.9
Operating Income
Operating Income (345.9) (274.3) (242.4) (226.2) (180.8) (162.2) (139.9) (153.0) (114.5) (196.7) (113.0) (87.1) (71.2) (86.6) (58.6) (47.9) (39.2) (29.8) (27.0) (23.7) (23.1) (19.5) (21.3) (21.2) (27.6) (15.8) (12.1) (12.2) (13.9)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0 0 0 0.0 0 0 0 0 0.0 0.0 0.0 0.0 0.0
Interest Income 26.6 26.5 29.3 31.1 32.9 36.5 28.1 23.8 21.7 17.6 18.5 16.5 10.4 6.6 1.2 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.2
Profitability
EBITDA (340.0) (234.6) (209.8) (161.6) (175.9) (52.6) (135.1) (149.5) (111.4) (177.9) (108.9) (82.3) (68.2) (75.8) (55.6) (46.4) (36.7) (27.4) (25.8) (22.8) (22.6) (20.4) (20.7) (20.0) (26.8) (14.3) (11.0) (10.4) (13.4)
EBIT (345.9) (246.5) (212.8) (166.6) (180.8) (57.4) (139.6) (153.0) (114.5) (180.8) (111.4) (84.7) (70.5) (78.0) (57.9) (48.5) (39.1) (28.6) (26.6) (23.7) (23.1) (20.7) (21.0) (20.3) (27.1) (14.6) (11.3) (10.7) (13.7)
Income Before Tax (320.6) (246.5) (212.8) (166.6) (140.7) (137.1) (103.1) (128.7) (95.0) (180.8) (92.7) (68.3) (60.5) (78.0) (57.9) (48.5) (39.0) (28.6) (26.6) (23.7) (21.2) (20.7) (21.0) (20.3) (27.1) (14.6) (11.3) (10.7) (13.7)
Income Tax Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (320.6) (246.5) (212.8) (166.6) (140.7) (137.1) (103.1) (128.7) (95.0) (180.8) (92.7) (68.3) (60.5) (78.0) (57.9) (48.5) (39.0) (28.6) (26.6) (23.7) (21.2) (20.7) (21.0) (20.3) (27.1) (17.8) (11.3) (10.7) (13.7)
Per Share Data
EPS (Basic) -2.30 -1.81 -1.56 -1.22 -1.04 -1.12 -0.83 -1.10 -0.85 -1.73 -0.91 -0.70 -0.70 -1.03 -0.93 -0.80 -0.68 -0.52 -0.51 -0.46 -0.41 -0.41 -0.41 -0.42 -0.58 -0.83 -2.93 -2.90 -3.72
EPS (Diluted) -2.30 -1.81 -1.56 -1.22 -1.04 -1.12 -0.83 -1.10 -0.85 -1.73 -0.91 -0.70 -0.70 -1.03 -0.93 -0.80 -0.68 -0.52 -0.51 -0.46 -0.41 -0.41 -0.41 -0.42 -0.58 -0.83 -2.93 -2.90 -3.72
Shares Outstanding 139.5 136.1 136.2 136.0 135.7 122.8 123.7 117.3 111.7 104.4 101.7 98.1 86.2 75.5 62.0 60.8 57.5 54.7 52.2 51.5 51.2 51.0 50.9 48.8 46.8 25.3 3.9 3.7 3.7
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q1
Current Assets
Cash & Cash Equivalents 260.8 174.0 281.1 306.7 346.9 387.9 1,050.2 518.7 611.5 397.5 545.1 531.0 380.5 834.7 278.4 238.2 201.7 69.0 112.0 151.0 198.9 386.2 397.0 410.0 154.8 59.0 (66.1)
Short-Term Investments 1,476.3 1,387 1,430.2 1,354.7 1,324.9 1,359.3 1,130.3 934.0 875.0 682.8 720.5 756.0 441.6 96.7 83.8 116.3 132.9 177.0 166.5 141.1 122.2 0 0 0 0 0 132.2
Net Receivables 0 46.6 0.4 0 0 0 17.9 17.9 0.1 0 1.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 76.3 2.8 55.4 54.3 44.8 40.8 4.9 1.4 30.5 15.7 1.3 23.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Current Assets 1,813.5 1,627.4 1,767.2 1,715.8 1,716.6 1,788.0 2,213.9 1,481.5 1,517.1 1,096.0 1,295.4 1,310.3 840.7 942.6 369.8 363.7 342.2 256.3 302.9 301.5 324.7 389.0 400.8 413.1 158.6 61.7 66.1
Non-Current Assets
Property, Plant & Equipment 373.8 491.7 337.0 327.9 304.9 332.6 249.9 203.3 157.3 145.3 27.8 34.4 34.9 31.6 32.8 34.7 36.3 35.9 6.9 6.3 6.0 3.3 2.5 2.8 3.3 3.4 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 1,005.5 883.1 960.7 1,165.1 1,279.0 1,387.5 1,092.6 399.2 413.2 162.7 168.6 153.7 127.8 26.5 4.0 6.9 17.7 27.1 39.7 48.8 49.8 0 0 0 0 0 0
Other Non-Current Assets 155.5 0.5 106.7 96.6 77.6 3.2 3.4 3.2 3.7 4.0 4.3 4.3 4.8 5.4 5.5 6.3 6.5 5.0 4.5 1.4 1.9 0.6 0.4 0.4 0.6 0.6 (66.1)
Total Non-Current Assets 1,534.8 1,418.6 1,404.4 1,589.6 1,661.5 1,723.3 1,345.9 605.8 574.2 312.0 200.6 192.5 167.5 63.6 42.3 47.9 60.5 68.0 51.1 56.5 57.6 3.8 3.0 3.2 3.9 4.0 (66.1)
Total Assets 3,348.3 3,046.0 3,171.6 3,305.4 3,378.1 3,511.3 3,559.7 2,087.3 2,091.3 1,407.9 1,496.1 1,502.8 1,008.2 1,006.2 412.1 411.6 402.7 324.3 354.1 358.1 382.4 392.8 403.8 416.2 162.5 65.7 0
Current Liabilities
Account Payables 63.1 70.9 49.0 31.4 20.5 48.5 18.2 10.5 21.7 14.6 15.7 16.3 11.6 9.8 5.5 7.0 4.8 6.8 25.7 23.7 31.9 29.8 10.7 2.6 2.6 3.4 0
Short-Term Debt 6.1 6.1 5.8 0 0 0 9.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 165.0 105.7 128.6 10.8 6.0 20.6 83.7 6.5 3.1 11.1 6.9 4.4 1.9 1.2 3.5 2.1 1.3 3.5 2.1 1.4 1.0 0.3 1.5 0.8 0.4 0.4 0
Total Current Liabilities 242.1 205.8 200.0 154.5 97.0 140.2 123.8 82.8 87.1 145.3 85.6 60.2 52.7 40.5 39.3 30.5 27.2 28.7 47.5 40.7 55.0 46.9 39.6 32.9 24.5 11.1 0
Non-Current Liabilities
Long-Term Debt 0 111.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 43.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 (111.3) 0 0 0 0.1 0 0 0 0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 161.0 0
Total Non-Current Liabilities 110.2 154.7 78.7 79.5 81.1 65.3 18.3 18.3 20.2 22.1 7.8 9.2 10.6 12.0 13.4 14.7 15.9 11.6 0.7 0.3 0.4 0.1 0.1 0.1 0.2 161.0 0
Total Liabilities 352.3 360.5 278.7 234.0 178.1 205.5 142.1 101.1 107.3 167.4 93.3 69.4 63.4 52.6 52.8 45.1 43.2 40.3 48.1 41.0 55.4 47.0 39.7 33.0 24.7 172.1 0
Stockholders' Equity
Common Stock 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0
Retained Earnings (2,475.6) (2,154.9) (1,908.4) (1,695.6) (1,529.0) (1,388.3) (1,251.2) (1,148.1) (1,019.4) (924.4) (743.6) (650.9) (582.6) (522.1) (444.1) (386.2) (337.6) (298.6) (270.1) (243.5) (219.8) (198.6) (177.8) (156.8) (136.5) (109.3) 0
Accumulated Other Comprehensive Income (6.8) 1.6 0.9 (1.9) (0.3) (3.9) 0.1 1.8 2.9 0.2 (2.3) (2.5) 0.0 (0.4) (0.7) (0.9) (0.8) (0.2) (0.0) (0.0) (0.0) 0 0 0 0 0 (57.7)
Total Stockholders' Equity 2,996.0 2,685.5 2,892.9 3,071.3 3,200.0 3,305.8 3,417.6 1,986.1 1,984.0 1,240.5 1,402.7 1,433.4 944.8 953.6 359.3 366.5 359.5 284.0 306.0 317.0 326.9 345.8 364.1 383.2 137.8 (106.4) 60.5
Total Liabilities & Equity 3,348.3 3,046.0 3,171.6 3,305.4 3,378.1 3,511.3 3,559.7 2,087.3 2,091.3 1,407.9 1,496.1 1,502.8 1,008.2 1,006.2 412.1 411.6 402.7 324.3 354.1 358.1 382.4 392.8 403.8 416.2 162.5 65.7 60.5
Debt Metrics
Total Debt 116.3 228.8 84.4 85.8 87.2 71.1 28.0 25.6 27.4 29.2 13.8 15.2 16.6 17.9 19.8 21.2 22.4 16.8 1.2 0.9 1.1 0 0 0 0 0.2 0
Net Debt (144.5) 54.9 (196.6) (220.9) (259.6) (316.8) (1,022.2) (493.1) (584.1) (368.2) (531.3) (515.8) (363.9) (816.7) (258.6) (217.0) (179.3) (52.2) (110.9) (150.1) (197.8) (386.2) (397.0) (410.0) (154.8) (58.8) 66.1
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Operating Activities
Net Income (320.6) (246.5) (212.8) (166.6) (140.7) (137.1) (103.1) (128.7) (95.0) (180.8) (92.7) (68.3) (60.5) (78.0) (57.9) (48.5) (39.0) (28.6) (26.6) (23.7) (21.2) (20.7) (21.0) (20.3) (27.1) (14.6) (11.3) (10.7) (13.7)
Depreciation & Amortization 5.9 9.8 5.2 5.0 4.9 4.8 4.5 3.5 3.1 2.9 2.5 2.4 2.3 2.3 2.4 2.2 2.4 1.2 0.9 0.9 0.5 0.3 0.3 0.4 0.4 0.3 0.3 0.3 0.3
Stock-Based Compensation 0 36.0 35.3 36.9 30.6 24.4 21.3 21.6 17.6 13.3 13.2 12.5 9.6 7.0 6.6 5.9 4.1 3.2 2.9 2.8 1.9 1.9 1.8 1.3 0.4 0.4 0.3 0.3 0.3
Change in Working Capital (2.9) 3.7 32.1 33.7 (49.5) (2.5) 29.2 (7.8) (73.8) 38.1 34.0 2.5 6.8 (3.3) 10.6 1.0 4.4 (27.5) (6.1) (9.0) 5.5 7.7 5.8 9.2 12.6 0.2 2.1 (2.0) 3.6
Other Non-Cash Items 37.1 (27.8) (3.1) (30.2) (11.5) (1.0) (12.6) (9.9) (11.0) (2.4) (14.6) (11.8) (6.0) 6.8 (0.2) 0.3 0.4 0.6 0.5 0.3 0.2 0.0 0.0 0.3 0.2 (0.7) (0.8) (1.4) (0.2)
Operating Cash Flow (280.6) (224.8) (143.3) (121.2) (166.3) (111.4) (60.7) (121.4) (159.1) (128.8) (57.5) (62.7) (47.7) (65.2) (38.5) (39.1) (27.7) (51.1) (28.4) (28.7) (13.2) (10.8) (13.1) (9.2) (13.6) (14.4) (9.5) (13.5) (9.8)
Investing Activities
Capital Expenditure (14.8) 5.6 (12.0) 19.5 (26.8) (30.0) (38.1) (45.4) (12.1) (57.1) (7.3) 2.1 (5.6) (1.1) (0.8) (0.9) (2.9) (1.4) (1.7) (2.2) (1.2) (0.7) (0.0) (0.1) (0.3) (1.0) (0.1) (0.2) (0.0)
Acquisitions 0 0 0 0 0 0 0 0 0 0 (0.0) 0.3 0.4 0.0 (0.0) (0.0) 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (584.1) (292.6) (255.3) (349.1) (314.5) (815.2) (1,233.1) (350.6) (687.7) (203.6) (209.7) (432.8) (483.8) (71.3) (17.6) (6.9) (7.0) (41.1) (66.7) (56.4) (172.1) 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 365.5 416.2 388.5 436.5 464.6 288.1 354.2 309.2 248.7 246.8 239.3 97.1 41.3 36.5 53.1 34 59.6 42.5 50.0 38.1 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 (14.0) 0 (29.3) 0 0 0 6.4 0 0 0.0 (0.3) (0.4) (0.0) 0.0 0.0 0.0 0.0 0 0 0 0 0.1 0 0 0 0 0 0
Investing Cash Flow (233.4) 115.1 121.2 77.7 123.3 (557.2) (917.0) (80.4) (451.1) (13.9) 22.3 (333.6) (448.1) (36.0) 34.7 26.2 49.7 0.1 (18.5) (20.5) (173.4) (0.7) 0.0 (0.1) (0.3) (1.0) (0.1) (0.2) (0.0)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.0) (0.1) (0.1) (0.1) (0.1) (0.1)
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (9.3) 5.9 (4.0) (0.7) 0.8 4.9 2.4 3.8 1.7 2.8 (0.5) 1.7 (0.2) 3.0 0.9 0.9 0.3 2.0 0.5 1.0 0.5 0.6 0.0 264.5 (0.0) (1.1) 0.4 0.0 0
Financing Cash Flow 601.6 2.4 (3.7) 2.5 0.8 4.9 1,515.0 110.4 818.2 2.7 48.5 547.0 41.6 656.6 44.0 49.9 111.0 8.8 7.6 1.0 0.5 0.6 0.0 264.5 109.8 41.4 0.4 (0.1) (0.1)
Cash Position
Net Change in Cash 86.9 (107.1) (25.5) (40.1) (41.0) (662.3) 531.7 (92.8) 214.1 (147.7) 14.3 150.6 (454.2) 556.3 40.2 36.4 132.8 (43.1) (39.0) (47.9) (186.4) (10.8) (13.0) 255.3 95.8 25.7 (9.2) (13.8) (9.9)
Cash at Beginning 174.0 282.5 308.1 348.2 389.2 1,051.5 519.8 611.5 398.6 546.2 531.9 381.3 835.5 279.3 239.0 202.6 69.9 112.9 151.9 199.8 386.2 397.0 410.0 154.8 59.0 33.3 42.5 56.2 66.1
Cash at End 260.8 175.4 282.5 308.1 348.2 389.2 1,051.5 518.7 612.6 398.6 546.2 531.9 381.3 835.5 279.3 239.0 202.6 69.9 112.9 151.9 199.8 386.2 397.0 410.0 154.8 59.0 33.3 42.5 56.2
Free Cash Flow (295.4) (219.3) (155.4) (101.7) (193.0) (141.4) (98.8) (166.8) (171.2) (185.9) (64.9) (60.6) (53.3) (66.4) (39.4) (40.1) (30.6) (52.5) (30.1) (30.9) (14.5) (11.5) (13.1) (9.2) (14.0) (15.4) (9.5) (13.7) (9.8)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Income Statement
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit (5.9) 5.0 0 (5.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Income (345.9) (274.3) (242.4) (226.2) (180.8) (162.2) (139.9) (153.0) (114.5) (196.7) (113.0) (87.1) (71.2) (86.6) (58.6) (47.9) (39.2) (29.8) (27.0) (23.7) (23.1) (19.5) (21.3) (21.2) (27.6) (15.8) (12.1) (12.2) (13.9)
Net Income (320.6) (246.5) (212.8) (166.6) (140.7) (137.1) (103.1) (128.7) (95.0) (180.8) (92.7) (68.3) (60.5) (78.0) (57.9) (48.5) (39.0) (28.6) (26.6) (23.7) (21.2) (20.7) (21.0) (20.3) (27.1) (17.8) (11.3) (10.7) (13.7)
EPS (Diluted) -2.30 -1.81 -1.56 -1.22 -1.04 -1.12 -0.83 -1.10 -0.85 -1.73 -0.91 -0.70 -0.70 -1.03 -0.93 -0.80 -0.68 -0.52 -0.51 -0.46 -0.41 -0.41 -0.41 -0.42 -0.58 -0.83 -2.93 -2.90 -3.72
Balance Sheet
Cash & Equivalents 260.8 174.0 281.1 306.7 346.9 387.9 1,050.2 518.7 611.5 397.5 545.1 531.0 380.5 834.7 278.4 238.2 201.7 69.0 112.0 151.0 198.9 386.2 397.0 410.0 154.8 59.0 (66.1)
Total Assets 3,348.3 3,046.0 3,171.6 3,305.4 3,378.1 3,511.3 3,559.7 2,087.3 2,091.3 1,407.9 1,496.1 1,502.8 1,008.2 1,006.2 412.1 411.6 402.7 324.3 354.1 358.1 382.4 392.8 403.8 416.2 162.5 65.7 0
Total Debt 116.3 228.8 84.4 85.8 87.2 71.1 28.0 25.6 27.4 29.2 13.8 15.2 16.6 17.9 19.8 21.2 22.4 16.8 1.2 0.9 1.1 0 0 0 0 0.2 0
Stockholders' Equity 2,996.0 2,685.5 2,892.9 3,071.3 3,200.0 3,305.8 3,417.6 1,986.1 1,984.0 1,240.5 1,402.7 1,433.4 944.8 953.6 359.3 366.5 359.5 284.0 306.0 317.0 326.9 345.8 364.1 383.2 137.8 (106.4) 60.5
Cash Flow
Operating Cash Flow (280.6) (224.8) (143.3) (121.2) (166.3) (111.4) (60.7) (121.4) (159.1) (128.8) (57.5) (62.7) (47.7) (65.2) (38.5) (39.1) (27.7) (51.1) (28.4) (28.7) (13.2) (10.8) (13.1) (9.2) (13.6) (14.4) (9.5) (13.5) (9.8)
Capital Expenditure (14.8) 5.6 (12.0) 19.5 (26.8) (30.0) (38.1) (45.4) (12.1) (57.1) (7.3) 2.1 (5.6) (1.1) (0.8) (0.9) (2.9) (1.4) (1.7) (2.2) (1.2) (0.7) (0.0) (0.1) (0.3) (1.0) (0.1) (0.2) (0.0)
Free Cash Flow (295.4) (219.3) (155.4) (101.7) (193.0) (141.4) (98.8) (166.8) (171.2) (185.9) (64.9) (60.6) (53.3) (66.4) (39.4) (40.1) (30.6) (52.5) (30.1) (30.9) (14.5) (11.5) (13.1) (9.2) (14.0) (15.4) (9.5) (13.7) (9.8)